Bio Spectrum - November 2019Add to Favorites

Bio Spectrum - November 2019Add to Favorites

Obtén acceso ilimitado con Magzter ORO

Lea Bio Spectrum junto con 8,500 y otras revistas y periódicos con solo una suscripción   Ver catálogo

1 mes $9.99

1 año$99.99

$8/mes

(OR)

Suscríbete solo a Bio Spectrum

1 año$11.88 $7.99

Guardar 33% International Workers Day!. ends on May 3, 2024

comprar esta edición $0.99

Regalar Bio Spectrum

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

Verified Secure Payment

Seguro verificado
Pago

En este asunto

Digitization improves lab supply chain management

Time is a major obstacle for the invention of a new product or for the development of a novel product from basic concepts. The time taken for an idea to be proved, prototyped and developed into beneficial invention determines the success of the product as there are multiple competitors existing in the market. As a result, scientists have to manage their time efficiently while executing their projects. However, unfortunately a lot of time is wasted when the required lab supplies such as reagents, kits, consumables, equipment etc. are not available while conducting crucial research experiments. Scientists often struggle in contacting the right biosuppliers, establishing trust with a new brand of product or facing delays in the delivery of an urgent material.

India Announces Major Tax Cuts To Boost Investment

USV Private Limited, an Indian multinational pharmaceutical, and biotechnology company based in Mumbai reacting quickly to the developments and leveraging on the government’s surprise corporate tax rate cut on September 20 announced that it will proceed with its investment of Rs 400 crore on a new state-of-art formulation plant at Vadodara in Gujarat.

India Announces Major Tax Cuts To Boost Investment

5 mins

Digitization Improves Lab Supply Chain Management

Time is a major obstacle for the invention of a new product or for the development of a novel product from basic concepts. The time taken for an idea to be proved, prototyped and developed into beneficial invention determines the success of the product as there are multiple competitors existing in the market. As a result, scientists have to manage their time efficiently while executing their projects. However, unfortunately a lot of time is wasted when the required lab supplies such as reagents, kits, consumables, equipment etc. are not available while conducting crucial research experiments. Scientists often struggle in contacting the right biosuppliers, establishing trust with a new brand of product or facing delays in the delivery of an urgent material.

Digitization Improves Lab Supply Chain Management

9 mins

'We Have Developed Over 15000 NCEs This Year'

A leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development, TCG Lifesciences Pvt. Limited started its operations in 2001 in Kolkata and currently has a presence in the United States, Europe, and Japan.

'We Have Developed Over 15000 NCEs This Year'

5 mins

'PPPs, CoEs Are Needed To Practice Precision Diabetes Care'

Roche Diabetes Care India, a pioneer in the development of diabetes management systems and services, has appointed executive from Novo Nordisk, Omar Sherief Mohammad as the new General Manager for its India business.

'PPPs, CoEs Are Needed To Practice Precision Diabetes Care'

5 mins

Leer todas las historias de Bio Spectrum

Bio Spectrum Magazine Description:

EditorMM Activ Sci-Tech Communication

CategoríaBusiness

IdiomaEnglish

FrecuenciaMonthly

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

  • cancel anytimeCancela en cualquier momento [ Mis compromisos ]
  • digital onlySolo digital
MAGZTER EN LA PRENSA:Ver todo